Volker Schellenberger
Impact in
- Biotechnology top 2%
- Molecular Biology top 5%
- Chemical Synthesis and Analysis
- Biochemical and Structural Characterization
- Enzyme Catalysis and Immobilization
- RNA and protein synthesis mechanisms
- Protein purification and stability
Papers in
- Oncology 20
- Peptidase Inhibition and Analysis 12
- CAR-T cell therapy research 8
- Co-authors
- Hans‐Dieter JakubkeWilliam J. RutterChristoph W. TurckBenjamin SpinkChia‐Wei WangRonald A. SiegelWillem P.C. StemmerJeffrey L. Cleland
- Journals
- Blood (5 papers)Biotechnology and Bioengineering (4 papers)Biochemistry (3 papers)Cancer Research (3 papers)European Journal of Biochemistry (3 papers)
- Partner nations
- GermanyUnited StatesRussia
In The Last Decade
Volker Schellenberger
62 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 102
- Biotechnology 219
- Molecular Biology 1.6k
- Radiology, Nuclear Medicine and Imaging 403
- Oncology 419
- Biomaterials 139
Countries citing papers authored by Volker Schellenberger
This map shows the geographic impact of Volker Schellenberger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Volker Schellenberger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Volker Schellenberger more than expected).
Fields of papers citing papers by Volker Schellenberger
This network shows the impact of papers produced by Volker Schellenberger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Volker Schellenberger. The network helps show where Volker Schellenberger may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Volker Schellenberger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 1 | |
| 2 | 2015 | 126 | |
| 3 | 2013 | 36 | |
| 4 | 2012 | 57 | |
| 5 | 2010 | 40 | |
| 6 | 2007 | 5 | |
| 7 | 2001 | 49 | |
| 8 | 2000 | 22 | |
| 9 | 1995 | 38 | |
| 10 | 1994 | 75 | |
| 11 | 1993 | 6 | |
| 12 | 1993 | 77 | |
| 13 | 1993 | 39 | |
| 14 | 1992 | 2 | |
| 15 | 1991 | 18 | |
| 16 | 1991 | 32 | |
| 17 | 1991 | 15 | |
| 18 | 1991 | 15 | |
| 19 | 1990 | 9 | |
| 20 | 1989 | 17 |
About Volker Schellenberger
Volker Schellenberger is a scholar working on Biotechnology, Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Hematology, having authored 62 papers that have together received 2.1k indexed citations. Recurring topics across this work include Chemical Synthesis and Analysis (23 papers), Monoclonal and Polyclonal Antibodies Research (15 papers), Peptidase Inhibition and Analysis (12 papers), CAR-T cell therapy research (8 papers), Biochemical and Molecular Research (7 papers), Biochemical and Structural Characterization (7 papers), Enzyme Catalysis and Immobilization (6 papers) and Protein Hydrolysis and Bioactive Peptides (6 papers). The work is most often cited by research in Biotechnology (219 citations), Molecular Biology (1.6k citations), Radiology, Nuclear Medicine and Imaging (403 citations), Oncology (419 citations) and Biomaterials (139 citations). Volker Schellenberger has collaborated with scholars based in Germany, United States and Russia. Frequent co-authors include Hans‐Dieter Jakubke, William J. Rutter, Christoph W. Turck, Benjamin Spink, Chia‐Wei Wang, Ronald A. Siegel, Willem P.C. Stemmer, Jeffrey L. Cleland, Vladimir N. Podust and Ute Schellenberger. Their work appears in journals such as Blood, Biotechnology and Bioengineering, Biochemistry, Cancer Research and European Journal of Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.